Literature DB >> 33805788

Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice.

Yi-Jen Liao1, Yuan-Hsi Wang1, Chien-Ying Wu1, Fang-Yu Hsu1, Chia-Ying Chien1, Yi-Chieh Lee1.   

Abstract

Persistent chronic liver diseases increase the scar formation and extracellular matrix accumulation that further progress to liver fibrosis and cirrhosis. Nevertheless, there is no antifibrotic therapy to date. The ketogenic diet is composed of high fat, moderate to low-protein, and very low carbohydrate content. It is mainly used in epilepsy and Alzheimer's disease. However, the effects of the ketogenic diet on liver fibrosis remains unknown. Through ketogenic diet consumption, β-hydroxybutyrate (bHB) and acetoacetate (AcAc) are two ketone bodies that are mainly produced in the liver. It is reported that bHB and AcAc treatment decreases cancer cell proliferation and promotes apoptosis. However, the influence of bHB and AcAc in hepatic stellate cell (HSC) activation and liver fibrosis are still unclear. Therefore, this study aimed to investigate the effect of the ketogenic diet and ketone bodies in affecting liver fibrosis progression. Our study revealed that feeding a high-fat ketogenic diet increased cholesterol accumulation in the liver, which further enhanced the carbon tetrachloride (CCl4)- and thioacetamide (TAA)-induced liver fibrosis. In addition, more severe liver inflammation and the loss of hepatic antioxidant and detoxification ability were also found in ketogenic diet-fed fibrotic mouse groups. However, the treatment with ketone bodies (bHB and AcAc) did not suppress transforming growth factor-β (TGF-β)-induced HSC activation, platelet-derived growth factor (PDGF)-BB-triggered proliferation, and the severity of CCl4-induced liver fibrosis in mice. In conclusion, our study demonstrated that feeding a high-fat ketogenic diet may trigger severe steatohepatitis and thereby promote liver fibrosis progression. Since a different ketogenic diet composition may exert different metabolic effects, more evidence is necessary to clarify the effects of a ketogenic diet on disease treatment.

Entities:  

Keywords:  acetoacetate; hepatic stellate cells; high-fat ketogenic diet; liver fibrosis; β-hydroxybutyrate

Mesh:

Substances:

Year:  2021        PMID: 33805788      PMCID: PMC7998170          DOI: 10.3390/ijms22062934

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  52 in total

Review 1.  TGF-beta/Smad signaling in the injured liver.

Authors:  K Breitkopf; P Godoy; L Ciuclan; M V Singer; S Dooley
Journal:  Z Gastroenterol       Date:  2006-01       Impact factor: 2.000

2.  β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.

Authors:  Yonglin Chen; Xinshou Ouyang; Rafaz Hoque; Irma Garcia-Martinez; Muhammad Nadeem Yousaf; Sarah Tonack; Stefan Offermanns; Laurent Dubuquoy; Alexandre Louvet; Philippe Mathurin; Veronica Massey; Bernd Schnabl; Ramon Alberola Bataller; Wajahat Zafar Mehal
Journal:  J Hepatol       Date:  2018-04-27       Impact factor: 25.083

3.  Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.

Authors:  Ali Hashemi Kani; Seyed Moayed Alavian; Ahmad Esmaillzadeh; Peyman Adibi; Leila Azadbakht
Journal:  Nutrition       Date:  2013-12-02       Impact factor: 4.008

Review 4.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

5.  Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat.

Authors:  Niina Matikainen; Marja-Riitta Taskinen; Sanna Stennabb; Nina Lundbom; Antti Hakkarainen; Kirsi Vaaralahti; Taneli Raivio
Journal:  Eur J Endocrinol       Date:  2011-12-21       Impact factor: 6.664

6.  Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis.

Authors:  Patrycja Puchalska; Shannon E Martin; Xiaojing Huang; Justin E Lengfeld; Bence Daniel; Mark J Graham; Xianlin Han; Laszlo Nagy; Gary J Patti; Peter A Crawford
Journal:  Cell Metab       Date:  2018-11-15       Impact factor: 27.287

7.  Short-term and divergent regulation of FGF-19 and FGF-21 during oral lipid tolerance test but not oral glucose tolerance test.

Authors:  A Schmid; S Leszczak; I Ober; T Karrasch; A Schäffler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2015-02-05       Impact factor: 2.949

8.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

Review 9.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

10.  HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma.

Authors:  Yuan-Hsi Wang; Chao-Lien Liu; Wan-Chun Chiu; Yuh-Ching Twu; Yi-Jen Liao
Journal:  Cancers (Basel)       Date:  2019-11-26       Impact factor: 6.639

View more
  4 in total

Review 1.  Ketogenic Diets and Hepatocellular Carcinoma.

Authors:  Yan Lan; Chaonan Jin; Pavitra Kumar; Xia Yu; Cameron Lenahan; Jifang Sheng
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

2.  Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage.

Authors:  Shandiz Morega; Bogdan Cătălin; Cristiana Eugenia Simionescu; Konstantinos Sapalidis; Ion Rogoveanu
Journal:  Brain Sci       Date:  2021-12-09

3.  Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics.

Authors:  Xiaofei Shang; Huixin Yuan; Lixia Dai; Yang Liu; Jian He; Huan Chen; Hongyan Li; Xiuhui Li
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810

4.  Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH.

Authors:  Einat Rauchbach; Haim Zeigerman; Diana Abu-Halaka; Oren Tirosh
Journal:  Antioxidants (Basel)       Date:  2022-03-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.